China Dr Yi (York) Chen, VP for operations and commercial planning at Arctic Vision shares his priorities, his wide experience of ophthalmology product launches in China, and how the company is positioning itself in relation to much larger companies in the Chinese ophthalmology market. Fundamentally, we are convinced that the…
China Founded by a veteran industry team, Arctic Vision recently celebrated its first anniversary and touts itself as the first innovative ophthalmology-focused biotech in China, with the mission of bringing innovative therapies from abroad to patients in China. According to CEO and cofounder Dr Eddy WU, a company like Arctic…
China Dr Eddy Wu, founder and CEO of new Chinese ophthalmology biotech Arctic Vision outlines the specific unmet ophthalmology needs in the Chinese market, the company’s burgeoning international partnerships, exciting portfolio, and Dr Wu’s own personal leadership journey. From an R&D perspective … what is critical in ophthalmology is the…
Cell & Gene Therapy The cell and gene therapy market was valued at USD 6 billion in 2017 and is projected to exceed USD 35 billion in value by 2026. Moreover, these therapies stand to redefine medical paradigms by providing treatments for previously incurable diseases and usher in a new era of precise and…
Sweden Sweden is fast staking a claim as one of Europe’s premier biotech hotspots thanks to a holistic approach to research projects, a strong institutional ecosystem, and increasingly easy access to funding at the early stages of biotech companies’ development. Collaboration “The Swedish innovation powerhouse is propelled by our excellent…
Puerto Rico Based in Tampa, Florida, Romark is a research-based pharmaceutical company focused on developing innovative treatments for infectious diseases. The company recently inaugurated its first finished products manufacturing facilities in Puerto Rico, transforming itself into a vertically integrated organization. CEO Marc Ayers extols the strengths of Puerto Rico as manufacturing location…
Europe Awareness is growing of the dangers of healthcare-associated infections (HAIs) in Europe, and conversations are beginning to taking place around how to leverage data to combat these infections and antimicrobial resistance (AMR). A panel of experts from diverse backgrounds at the European Health Forum Gastein put their heads together to…
Sweden Infectious diseases kill over 17 million people each year, according to the WHO, which is why vaccine-specialist Valneva is continuing to grow and develop the next generation of vaccines. Janet Hoogstraate, chair of the Management Board of Valneva Sweden, explains the high-quality of their manufacturing operations in the country and…
Sweden Swedish firm Orexo AB, despite its relatively small stature, is playing a major role in combating one of the USA’s biggest public health emergencies – the opioid crisis. Orexo, most widely known for its opioid dependence drugs, was founded in 1995 in Uppsala, Sweden. Its top-selling product is Zubsolv,…
Taiwan United Biomedical, Inc. (UBI) is dedicated to the discovery, development, and commercialization of immunotherapies & vaccines for chronic and infectious diseases and is passionate about delivering science-driven innovation with platform capabilities. Chang Yi Wang is the Chairperson and CSO of United BioPharma (UBP), a member of the UBI group of…
Puerto Rico Founded in 2004, Villavicencio & Associates Construction is a dynamic Puerto Rican construction firm which has been involved in many different projects in the pharmaceutical industry. President Lisette Villavicencio explains how the company has managed to grow steadily throughout Puerto Rico’s economic downturn by focusing on safety, quality and integrity.…
Sweden BioArctic is a Swedish biopharma company with the vision to become a world-leader in the research and development of disease-modifying treatments for patients with neurodegenerative diseases, such as Alzheimer’s disease and Parkinson’s disease, and pioneering treatment methods for complete spinal cord injuries. Gunilla Osswald, CEO, explains how BioArctic is uniquely…
See our Cookie Privacy Policy Here